This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Ludwig-Maximilians-Universitat München, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2021
Title: The Innovations of Margarete Schön: A Pioneer in Melanoma Treatment
Introduction: Margarete Schön, an accomplished inventor based in Bovenden, Germany, has made significant contributions to the field of medical research with her innovative patent related to the treatment of melanoma. Her work highlights the vital intersection of scientific inquiry and practical application in the fight against cancer.
Latest Patents: Margarete Schön holds a patent for "Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma." This invention pertains to a compound described by a specific chemical formula that aims to enhance treatment options for individuals afflicted with melanoma, a serious type of skin cancer.
Career Highlights: Throughout her career, Margarete Schön has worked with renowned institutions, including the Max Planck Society for the Advancement of Science and Ludwig Maximilians University Munich. These affiliations have allowed her to engage with cutting-edge research and leverage collaborative efforts to push the boundaries of scientific understanding.
Collaborations: In her pursuit of innovation, Margarete Schön has collaborated with notable professionals such as Dorothea Becker and Thomas M. Jovin. These partnerships have significantly enriched her research endeavors and contributed to the development of novel therapeutic strategies in oncology.
Conclusion: Margarete Schön exemplifies the spirit of innovation in medicine through her dedicated work in developing treatments for melanoma. With her patent and collaborative efforts, she continues to inspire future generations of inventors in the quest to improve health outcomes and tackle complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile